Listed by the USPTO as KENYON, JOHN S
Tech Center 1700 • Art Units: 1622 1625 1629 1758
This examiner grants 80% of resolved cases
KENYON, JOHN S is a USPTO patent examiner in tech center 1700 and art unit 1622. The profile covers 958 resolved cases, with an allowance rate of 79.7% and a median of 859 days to allowance. Interview lift is 18.2%, suggesting that interviews can support progress but are best integrated with clear written treatment of the claims and cited art.
The leading companies are Gibson Oncology LLC, Novartis AG, and Cedars-Sinai Medical Center. The leading firms are HODGSON RUSS LLP, SUGHRUE MION, PLLC, and Amundsen Davis, LLC. Applicants should identify the technical and legal issues early, use interviews to resolve focused questions, and account for the recorded timing when planning responses and portfolio milestones.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18696753 | SURFACTANT STABILIZERS | Non-Final OA | NOVARTIS AG |
| 18558351 | CRYSTAL FORM IV OF ORGANIC ACID SALTS OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND PREPARATION METHOD THEREOF | Non-Final OA | LG CHEM, LTD. |
| 18560233 | COMBINATION THERAPIES | Non-Final OA | Janssen Pharmaceutica NV |
| 17777910 | TRPM8 MODULATORS | Non-Final OA | Givaudan SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy79.7% of resolved applications examined by John S Kenyon were allowed (958 resolved cases), compared with 60.6% across Art Unit 1622 over the last five years.
This examiner's interview lift is +18.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by John S Kenyon took 859 days on average from filing to allowance.
John S Kenyon examines applications in Art Unit 1622 in Tech Center 1700 (Chemistry & Materials).
